Novalis LifeSciences

Novalis LifeSciences operates as a specialized investment and advisory firm dedicated to the life science industry. The company provides direct capital through Novalis LifeSciences, managing venture capital and private equity funds totaling $500 million to deploy into businesses focused on life science tools, diagnostics, and biopharma therapeutics. Concurrently, Novalis Advisory offers strategic guidance, including investment banking services, operational consulting, and executive development, to foster growth and efficiency within its portfolio.

The firm was founded in 2017 by Marijn E. Dekkers, who serves as Chairman. Dekkers’ extensive background as the former CEO of Bayer AG and Thermo Fisher Scientific, alongside his experience as Chairman of Unilever, shaped the firm's foundational insight: to pair substantial capital with deep operational expertise to support promising ventures. His distinguished career as both a scientist and a corporate leader underpins the strategic approach of Novalis.

Novalis LifeSciences primarily serves visionary entrepreneurs and companies within the broad life science sector, providing both financial backing and seasoned strategic input. The company aims to facilitate the development and commercialization of innovative solutions across diagnostics, tools, and biopharmaceuticals. Its overarching vision is to cultivate impactful advancements within the life science landscape by empowering its portfolio companies through active partnership and strategic resources.